Dare Bioscience
DARE
38 hedge funds and large institutions have $13.7M invested in Dare Bioscience in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 5 reducing their positions, and 7 closing their positions.
180% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 5
70% more capital invested
Capital invested by funds: $8.07M → $13.7M (+$5.67M)
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
3% more funds holding
Funds holding: 37 → 38 (+1)
0.18% more ownership
Funds ownership: 0.57% → 0.75% (+0.18%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$2.38M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.53M |
| 3 |
BlackRock
New York
|
+$420K |
| 4 |
Two Sigma Investments
New York
|
+$244K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$223K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$541K |
| 2 |
Jane Street
New York
|
-$213K |
| 3 |
VF
Virtu Financial
New York
|
-$156K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$144K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$124K |
DARE Hedge Fund Activity: Q4 2021 in Review
38 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q4 2021, worth a combined $13.7M — up 70% from $8.07M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new DARE positions and 7 closed out — a net gain of 2 holders — while 14 added to existing stakes and 5 trimmed.
The largest buyer was Marshall Wace, opening a new position worth an estimated $2.38M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $541K sold.
- 38 institutional investors held Dare Bioscience (DARE) as of Q4 2021, up from 37 in Q3 2021.
- Funds reported $13.7M of Dare Bioscience stock for Q4 2021, up 70% quarter-over-quarter.
- 9 funds opened new Dare Bioscience positions in Q4 2021 and 7 closed out, a net change of +2 holders.
- The largest Dare Bioscience buyer in Q4 2021 was Marshall Wace, an estimated $2.38M added.
- The largest Dare Bioscience seller in Q4 2021 was Renaissance Technologies, an estimated $541K sold.
Based on aggregated 13F filings for Q4 2021.